搜索临床试验以：Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics,
总计52802个结果
-
Novartis Pharmaceuticals完全的Mild Moderate | or Severe Renal Impairment德国
-
Pfizer完全的
-
Parc de Salut MarNational Institute on Drug Abuse (NIDA)完全的
-
Novartis Pharmaceuticals完全的
-
GlaxoSmithKlineMedicines for Malaria Venture完全的
-
AstraZeneca完全的药代动力学 | 安全 | Pharmacodynamics of AZD7594英国
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
AstraZeneca完全的
-
GlaxoSmithKline终止
-
Taipei Veterans General Hospital, TaiwanTaipei City Hospital完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的健康受试者 | 艾沙康唑的药代动力学 | Pharmacokinetics of Sirolimus美国
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Astellas Pharma IncBasilea Pharmaceutica International Ltd完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的健康受试者 | 艾沙康唑的药代动力学 | Pharmacokinetics of Prednisolone美国
-
Astellas Pharma IncBasilea Pharmaceutica International Ltd完全的